Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Clinical_Trials
|
| gptkbp:end_date |
2023-12-31
|
| gptkbp:focus |
gptkb:neurodegenerative_diseases
|
| https://www.w3.org/2000/01/rdf-schema#label |
AEGIS Study
|
| gptkbp:is_tested_for |
Phase 3
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:participants |
gptkb:500
|
| gptkbp:prevention |
drug therapy
|
| gptkbp:result |
to be published
|
| gptkbp:sponsor |
gptkb:National_Institutes_of_Health
|
| gptkbp:start_date |
2020-01-01
|
| gptkbp:bfsParent |
gptkb:Lanadelumab
|
| gptkbp:bfsLayer |
6
|